These features support sustained signaling behavior compared to endogenous incretin peptides
On- and Off-label Use of GLP-1 and GIP/GLP-1 RAs* *GLP-1 and GIP/GLP-1 RAs include: Bydureon, Byetta, Victoza, Ozempic, Rybelsus, Adlyxin, Saxenda, Wegovy, Zepbound, Trulicity, Mounjaro
Qsymia is approved for chronic, long-term use, which separates it from phentermine alone (limited to 12 weeks in most prescribing guidance)
Some conditions that may also present with neck lumps include throat cancer or thyroid nodules
Why Canada moved first According to Amin, Novo Nordisk's patent on Ozempic could have been extended until 2028 in Canada but the company failed to renew it [Source: bbc.com/news/articles/c142y4p2eyxo]
Tirzepatides dual action can make side effects feel more intense for some patients, particularly during dose increases